中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
16期
1-2
,共2页
儿科%阿奇霉素%不良反应
兒科%阿奇黴素%不良反應
인과%아기매소%불량반응
Pediatrics%Azithromycin%Adverse reactions
目的：探讨儿科临床应用中阿奇霉素的不良反应。方法随机选取2012年10月-2014年10月该院收治的180例儿科患者临床资料，随机分为A组、B组，各90例。A组口服阿奇霉素治疗，B组选取静脉滴注阿奇霉素治疗，对比两组患儿临床不良反应。结果 A组胃肠道反应、发热、过敏性休克、过敏性皮疹等不良反应发生率分别为11.11%、7.78%、5.56%、2.22%，分别与B组的13.33%、10.00%、6.67%、4.44%对比，差异无统计学意义(P>0.05)。结论阿奇霉素在儿科临床应用中的不良反应包括胃肠道反应、过敏性休克、过敏性皮疹、发热等症状，在临床治疗中应该合理选取静脉滴注及口服方式，以降低不良反应发生率，确保较高的临床疗效。
目的：探討兒科臨床應用中阿奇黴素的不良反應。方法隨機選取2012年10月-2014年10月該院收治的180例兒科患者臨床資料，隨機分為A組、B組，各90例。A組口服阿奇黴素治療，B組選取靜脈滴註阿奇黴素治療，對比兩組患兒臨床不良反應。結果 A組胃腸道反應、髮熱、過敏性休剋、過敏性皮疹等不良反應髮生率分彆為11.11%、7.78%、5.56%、2.22%，分彆與B組的13.33%、10.00%、6.67%、4.44%對比，差異無統計學意義(P>0.05)。結論阿奇黴素在兒科臨床應用中的不良反應包括胃腸道反應、過敏性休剋、過敏性皮疹、髮熱等癥狀，在臨床治療中應該閤理選取靜脈滴註及口服方式，以降低不良反應髮生率，確保較高的臨床療效。
목적：탐토인과림상응용중아기매소적불량반응。방법수궤선취2012년10월-2014년10월해원수치적180례인과환자림상자료，수궤분위A조、B조，각90례。A조구복아기매소치료，B조선취정맥적주아기매소치료，대비량조환인림상불량반응。결과 A조위장도반응、발열、과민성휴극、과민성피진등불량반응발생솔분별위11.11%、7.78%、5.56%、2.22%，분별여B조적13.33%、10.00%、6.67%、4.44%대비，차이무통계학의의(P>0.05)。결론아기매소재인과림상응용중적불량반응포괄위장도반응、과민성휴극、과민성피진、발열등증상，재림상치료중응해합리선취정맥적주급구복방식，이강저불량반응발생솔，학보교고적림상료효。
Objective To investigate the adverse reactions of Azithromycin applied to Department of Pediatrics clinically. Methods The clinical data of 180 pediatric patients admitted in our hospital from October 2012 to October 2014 were selected. And the pa-tients were divided into group A and group B with 90 patients in each group. Group A were treated by Azithromycin orally, group B were treated by intravenous drip of Azithromycin. And the clinical adverse reactions were compared between the two groups. Results The incidence of gastrointestinal reaction, fever, anaphylactic shock, allergic rash and other adverse reactions in group A was 11.11%, 7.78%, 5.56%, 2.22%, respectively, and that in group B was 13.33%, 10.00%, 6.67%, 4.44%, respectively, with no statistically significant difference (P>0.05). Conclusion The adverse reactions of Azithromycin applied to Department of Pediatrics clinically mainly include gastrointestinal reaction, anaphylactic shock, allergic rash and fever and other symptoms. In order to re-duce the incidence of adverse reactions and ensure high clinical curative effect, oral or intravenous administration of Azithromycin in clinical treatment should be selected rationally.
